The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $88.86, a high ...

Shares of Acurx Pharmaceuticals inc. (NASDAQ: ACXP) are up on Tuesday following the publication of favorable clinical trial ...

SolarEdge is struggling in the U.S. and European markets; it's not among the companies that saw a surge in fundamentals.

FDA unveils a priority voucher program to accelerate drug reviews for national priorities, using a team-based review model.

RDW shares are trading higher Tuesday after the company announced the pricing of a major public stock offering.

Sage Therapeutics shares gained 0.4% to trade at $9.11 on Tuesday. These analysts made changes to their price targets on Sage ...

Lenacapavir, a twice-yearly HIV prevention shot by Gilead, could be produced for $25 a year but may sell for $25K, raising ...

Wedbush Fund Advisers CIO Cullen Rogers tells Benzinga: "We don't react to short-term performance or headlines." ...

Jabil Inc. JBL reported better-than-expected third-quarter results on Tuesday. The company reported quarterly adjusted ...

Shares of Digital Turbine Inc. (NASDAQ: APPS) are trading higher Tuesday after the company released its fourth-quarter ...

Vertiv Holdings Co (NYSE:VRT) is booming in the AI industry with a deal with Nvidia and an analyst upgrade, making it a ...

Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems.